Published in Arthritis Rheum on June 01, 1982
Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum (2009) 2.32
Disparities in lupus care and outcomes. Curr Opin Rheumatol (2009) 1.45
Corticosteroids: do they damage the cardiovascular system? Postgrad Med J (1994) 1.32
Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades. Ann Rheum Dis (2002) 1.21
High prevalence of systemic disease and mortality in Asian subjects with systemic lupus erythematosus. Ann Rheum Dis (1991) 1.10
Clinical characteristics and treatment outcomes of autoimmune-associated hemophagocytic syndrome in adults. Arthritis Rheumatol (2014) 1.09
Pathogenesis of experimental lupus nephritis: a role for anti-basement membrane and anti-tubular brush border antibodies in murine chronic graft-versus-host disease. Clin Exp Immunol (1990) 1.05
Ethnicity and mortality from systemic lupus erythematosus in the US. Ann Rheum Dis (2006) 1.04
Systemic lupus erythematosus. I. Outcome and survival: Dutch experience with 110 patients studied prospectively. Ann Rheum Dis (1989) 1.00
Environmental factors predicting nephritis in systemic lupus erythematosus. Ann Rheum Dis (1993) 0.99
Poverty, not ethnicity, accounts for the differential mortality rates among lupus patients of various ethnic groups. J Natl Med Assoc (2007) 0.99
Systemic lupus erythematosus on the Caribbean island of Curaçao: an epidemiological investigation. Ann Rheum Dis (1992) 0.95
Fcgamma receptor IIa, IIIa, and IIIb polymorphisms in German patients with systemic lupus erythematosus: association with clinical symptoms. Ann Rheum Dis (2002) 0.93
Development and initial validation of a self-assessed lupus organ damage instrument. Arthritis Care Res (Hoboken) (2010) 0.85
Outcome and survival in systemic lupus erythematosus. Ann Rheum Dis (1989) 0.84
Racial group, socioeconomic status, and the development of persistent proteinuria in systemic lupus erythematosus. Ann Rheum Dis (2000) 0.83
Childhood-onset systemic lupus erythematosus: a comparative study of African Americans and Latin Americans. J Natl Med Assoc (1999) 0.83
Incidence and prevalence of lupus in Buenos Aires, Argentina: a 11-year health management organisation-based study. Lupus Sci Med (2014) 0.83
A study of racial/ethnic differences in treatment preferences among lupus patients. Rheumatology (Oxford) (2012) 0.82
Assessment of lupus: where are we now? Ann Rheum Dis (1993) 0.81
Expression of systemic lupus erythematosus in various ethnic Jewish Israeli groups. Ann Rheum Dis (1993) 0.81
Critical illness in systemic lupus erythematosus and the antiphospholipid syndrome. Ann Rheum Dis (2002) 0.79
Low socioeconomic status is associated with cardiovascular risk factors and outcomes in systemic lupus erythematosus. J Rheumatol (2012) 0.78
Risk of infection in hospitalised children with systemic lupus erythematosus: a 10-year follow-up. Clin Rheumatol (2004) 0.78
Renal Interstitial Arteriosclerotic Lesions in Lupus Nephritis Patients: A Cohort Study from China. PLoS One (2015) 0.78
Survival rates and risk factors for mortality in systemic lupus erythematosus patients in a Chinese center. Clin Rheumatol (2014) 0.76
New methods of treatment in an experimental murine model of systemic lupus erythematosus induced by idiotypic manipulation. Ann Rheum Dis (1997) 0.75
Classifying lupus. Br Med J (Clin Res Ed) (1983) 0.75
Soluble CD95 concentrations are increased in patients with severe systemic lupus erythematosus, but not in their first degree relatives. Ann Rheum Dis (2001) 0.75
Intense immune suppression for systemic lupus--the role of hematopoietic stem cells. J Clin Immunol (2000) 0.75
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum (1988) 111.05
The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1982) 67.54
Viral dynamics in human immunodeficiency virus type 1 infection. Nature (1995) 28.54
Measurement of patient outcome in arthritis. Arthritis Rheum (1980) 21.31
Aging, natural death, and the compression of morbidity. N Engl J Med (1980) 17.40
Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol (1988) 16.45
Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol (1994) 15.93
ENZYME INDUCTION AS AN ALL-OR-NONE PHENOMENON. Proc Natl Acad Sci U S A (1957) 14.34
High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science (1993) 12.22
Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat Med (1997) 12.08
Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med (2000) 11.12
Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature (1999) 10.97
Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS. Cell (1986) 10.70
Timing the ancestor of the HIV-1 pandemic strains. Science (2000) 10.42
Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome. Science (1984) 10.40
The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum (1990) 8.67
The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. J Rheumatol (1983) 8.37
Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS. Science (1986) 7.81
HTLV-III infection in brains of children and adults with AIDS encephalopathy. Science (1985) 7.70
Deaths due to medical errors are exaggerated in Institute of Medicine report. JAMA (2000) 7.05
High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. N Engl J Med (1991) 7.01
Fibromyalgia: La Maladie est Morte. Vive le Malade! J Rheumatol (1997) 6.98
HIV-1 nomenclature proposal. Science (2000) 6.61
Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions. J Virol (1987) 6.20
The mortality of rheumatoid arthritis. Arthritis Rheum (1994) 6.18
Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol (1997) 6.10
Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa. AIDS Res Hum Retroviruses (2001) 6.00
Recombination in HIV-1. Nature (1995) 5.72
Osteoarthritis: new insights. Part 2: treatment approaches. Ann Intern Med (2000) 5.58
Criteria for the classification of early systemic sclerosis. J Rheumatol (2001) 5.39
Absorption of guinea pig serum with agar. A method for elimination of itscytotoxicity for murine thymus cells. Transplantation (1970) 5.37
Genomic diversity of human T-lymphotropic virus type III (HTLV-III). Science (1985) 5.33
Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo. J Virol (1992) 5.19
Genomic diversity of the acquired immune deficiency syndrome virus HTLV-III: different viruses exhibit greatest divergence in their envelope genes. Proc Natl Acad Sci U S A (1985) 5.10
Patterns of brain atrophy in frontotemporal dementia and semantic dementia. Neurology (2002) 5.03
Extensive variation of human immunodeficiency virus type-1 in vivo. Nature (1988) 5.02
Aging, health risks, and cumulative disability. N Engl J Med (1998) 4.97
Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med (1969) 4.76
Evaluation of a preliminary physical function item bank supported the expected advantages of the Patient-Reported Outcomes Measurement Information System (PROMIS). J Clin Epidemiol (2008) 4.55
Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants. J Virol (2009) 4.40
Cytotoxins in disease. Autocytotoxins in lupus. N Engl J Med (1970) 4.40
Molecular cloning and characterization of the HTLV-III virus associated with AIDS. Nature (1984) 4.35
Striking prevalence of ankylosing spondylitis in "healthy" w27 positive males and females. N Engl J Med (1975) 4.25
Truncation of the human immunodeficiency virus type 1 transmembrane glycoprotein cytoplasmic domain blocks virus infectivity. J Virol (1992) 4.20
Human infection by genetically diverse SIVSM-related HIV-2 in west Africa. Nature (1992) 4.11
Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial. Ann Intern Med (2000) 4.07
Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. N Engl J Med (1986) 4.01
Recombination in AIDS viruses. J Mol Evol (1995) 3.94
The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin. J Virol (1996) 3.82
Sjögren's syndrome (Sicca syndrome): current issues. Ann Intern Med (1980) 3.81
Biologically diverse molecular variants within a single HIV-1 isolate. Nature (1988) 3.80
Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon. Science (1982) 3.67
A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1. J Virol (1998) 3.65
The impact of managed care on patients' trust in medical care and their physicians. JAMA (1996) 3.61
HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo. Nat Med (1998) 3.61
Clinical history as a screening test for ankylosing spondylitis. JAMA (1977) 3.60
Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis Rheum (1994) 3.52
Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees. Proc Natl Acad Sci U S A (1998) 3.35
Criteria for rheumatic disease. Different types and different functions. The American College of Rheumatology Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum (1994) 3.24
Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases. N Engl J Med (1976) 3.22
A keyboard for "Daubert". J Occup Environ Med (1996) 3.22
Mosaic genome structure of simian immunodeficiency virus from west African green monkeys. EMBO J (1994) 3.19
Vpx is required for dissemination and pathogenesis of SIV(SM) PBj: evidence of macrophage-dependent viral amplification. Nat Med (1998) 3.19
Radiographic assessment of progression in osteoarthritis. Arthritis Rheum (1987) 3.11
The origins of acquired immune deficiency syndrome viruses: where and when? Philos Trans R Soc Lond B Biol Sci (2001) 3.10
Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res (2000) 3.03
Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum (2000) 3.02
Human lymphocyte subpopulations. Effect of corticosteroids. J Clin Invest (1974) 2.96
Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum (1988) 2.93
Midazolam kinetics. Clin Pharmacol Ther (1981) 2.88
The Health Assessment Questionnaire (HAQ). Clin Exp Rheumatol (2005) 2.88
Complete nucleotide sequence, genome organization, and biological properties of human immunodeficiency virus type 1 in vivo: evidence for limited defectiveness and complementation. J Virol (1992) 2.86
Nuclear import and cell cycle arrest functions of the HIV-1 Vpr protein are encoded by two separate genes in HIV-2/SIV(SM). EMBO J (1996) 2.84
Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis. Ann Intern Med (2001) 2.77
Quantitative studies of immunofluorescent staining. Relationships of characteristics of unabsorbed antihuman IgG conjugates to their specific and non-specific staining properties in an indirect test for antinuclear factors. Bull World Health Organ (1968) 2.72
Species-specific diversity among simian immunodeficiency viruses from African green monkeys. J Virol (1991) 2.70
Frequency, severity and duration of immune reconstitution events in HIV-related tuberculosis. Int J Tuberc Lung Dis (2007) 2.68
Maintaining the integrity of human immunodeficiency virus sequence databases. J Virol (1996) 2.68
NIH conference. The acquired immunodeficiency syndrome: an update. Ann Intern Med (1985) 2.68
Estimates of the prevalence of selected arthritic and musculoskeletal diseases in the United States. J Rheumatol (1989) 2.67
Antibodies to type II collagen in relapsing polychondritis. N Engl J Med (1978) 2.65
Carpal tunnel syndrome, diagnostic conundrum. J Rheumatol (1997) 2.64
Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia. Neurology (2004) 2.63
Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines. J Virol (1998) 2.63
A new sign (Fries' knees) for early detection of inflammation of the knee joint. J Rheumatol (1990) 2.62
Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus. J Clin Invest (1997) 2.57
Survival, prognosis, and causes of death in rheumatoid arthritis. Arthritis Rheum (1986) 2.55
Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J Exp Med (1994) 2.54
Thymus cells of radiation-chimeras: TL phenotype, sensitivity to guinea-pig serum, and origin from donor cells. Nature (1965) 2.54
Complement factor H gene mutation associated with autosomal recessive atypical hemolytic uremic syndrome. Am J Hum Genet (1999) 2.42
Therapy for severe interstitial lung disease in systemic sclerosis. A retrospective study. Arthritis Rheum (1994) 2.41
Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans. J Clin Invest (1996) 2.39
Restricted subpopulations of DNA antibodies in kidneys of mice with systemic lupus. Comparison of antibodies in serum and renal eluates. Arthritis Rheum (1980) 2.39
Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet (1992) 2.38
Privatization of psychiatric services. Am J Psychiatry (1988) 2.38
The health assessment questionnaire 1992: status and review. Arthritis Care Res (1992) 2.38
Incidence of systemic lupus erythematosus. Race and gender differences. Arthritis Rheum (1995) 2.38
Prognostic factors in lupus nephritis. Contribution of renal histologic data. Am J Med (1983) 2.38